Want to see CH:SANN full AI Analyst Report?
Santhera Pharmaceuticals Holding (SANN) Financial Statements
Santhera Pharmaceuticals Holding Financial Overview
Santhera Pharmaceuticals Holding's market cap is currently $234.69M. The company's EPS TTM is $-2.28; its P/E ratio is -6.72; Santhera Pharmaceuticals Holding has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Dec 23 | Mar 23 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 77.19M | $ 39.12M | $ 103.41M | $ 7.47M | $ -1.59M |
| Gross Profit | $ 14.47M | $ 22.96M | $ 100.18M | $ 3.88M | $ -5.36M |
| Operating Income | $ -37.82M | $ -33.38M | $ 68.84M | $ -51.98M | $ -56.89M |
| EBITDA | $ -32.13M | $ -15.89M | $ 79.17M | $ -46.78M | $ -34.57M |
| Net Income | $ -49.24M | $ -41.97M | $ 54.78M | $ -71.08M | $ -55.53M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 22.44M | $ 40.92M | $ 30.37M | $ 1.35M | $ 21.21M |
| Total Assets | $ 148.09M | $ 152.49M | $ 109.63M | $ 63.73M | $ 91.12M |
| Total Debt | $ 97.77M | $ 41.17M | $ 23.03M | $ 44.44M | $ 42.98M |
| Net Debt | $ 75.33M | $ 248.00K | $ -7.34M | $ 43.08M | $ 21.77M |
| Total Liabilities | $ 159.90M | $ 124.79M | $ 49.69M | $ 107.41M | $ 89.79M |
| Stockholders' Equity | $ -11.82M | $ 27.70M | $ 59.94M | $ -43.69M | $ 1.33M |
| Cash Flow | |||||
| Free Cash Flow | $ -34.81M | $ -35.68M | $ 23.53M | $ -33.80M | $ -37.37M |
| Operating Cash Flow | $ -34.76M | $ -35.53M | $ 47.27M | $ -29.84M | $ -37.36M |
| Investing Cash Flow | $ -122.00K | $ -61.00K | $ -18.04M | $ -3.93M | $ 69.00K |
| Financing Cash Flow | $ 16.38M | $ 46.08M | $ -171.00K | $ 13.99M | $ 46.02M |
Currency in CHF